PAA 8.89% 24.5¢ pharmaust limited

Ann: New patent granted for non-cancer applications, page-3

  1. 274 Posts.
    Column 1 Column 2
    0 PharmAust extends cancer drug to diabetes and brain diseasePerth listed biotech PharmAust, have determined that their promising anti-cancer drug known as MPL might also be useful in the treatment of diabetes, brain disease and age related disorders. The company announced this week they have secured a patent for MPL in Australia relating to the treatment of the three newly targeted illnesses.
    From BULLS N'BEARS
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.020(8.89%)
Mkt cap ! $96.99M
Open High Low Value Volume
22.5¢ 24.5¢ 22.5¢ $150.8K 649.5K

Buyers (Bids)

No. Vol. Price($)
2 30000 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 50607 2
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
24.0¢
  Change
0.020 ( 6.67 %)
Open High Low Volume
22.5¢ 24.0¢ 22.5¢ 231366
Last updated 15.56pm 17/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.